New drug shows promise for rare mitochondrial disease
Disease control
Completed
This study tested an experimental drug called OMT-28 in 28 adults with primary mitochondrial disease, a condition that affects energy production in cells. The goal was to see if the drug is safe and can improve blood markers and symptoms like fatigue. Participants took the drug d…
Phase: PHASE2 • Sponsor: Omeicos Therapeutics GmbH • Aim: Disease control
Last updated May 26, 2026 12:10 UTC